Skip to main
CCRN
CCRN logo

CCRN Stock Forecast & Price Target

CCRN Analyst Ratings

Based on 3 analyst ratings
Hold
Strong Buy 0%
Buy 0%
Hold 100%
Sell 0%
Strong Sell 0%

Bulls say

Cross Country Healthcare has shown stabilization in gross margin at 20.0%, maintaining this level from the previous quarter and exceeding prior estimates. The company is the subject of an acquisition agreement with Aya Healthcare, offering $18.61 per share in cash, representing a substantial 67% premium over its previous closing price. Additionally, the anticipated timeline for the transaction has shifted to the second half of 2025, providing an extended period for value realization for shareholders.

Bears say

Cross Country Healthcare's financial performance has shown significant deterioration, with Q1 2025 Adjusted EBITDA declining 44% year-over-year to $8.6 million, despite surpassing a prior estimate of $6.6 million. Revenue for the same period fell to $293.4 million, which not only missed estimates but also marked a 23% year-over-year decline, attributed to ongoing weak demand in the healthcare travel staffing sector. Furthermore, the company has revised its 2025 revenue forecast downward to $1.166 billion, representing a 13.3% year-over-year decrease from the previously projected $1.255 billion.

CCRN has been analyzed by 3 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 0% recommend Buy, 100% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cross Country Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cross Country Healthcare (CCRN) Forecast

Analysts have given CCRN a Hold based on their latest research and market trends.

According to 3 analysts, CCRN has a Hold consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17.91, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17.91, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cross Country Healthcare (CCRN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.